Immunization, Hib3 in Lower middle income
Lower middle income: Immunization, Hib3 was 86.6% in 2024. ◆ Volatile
Immunization, Hib3 in Lower middle income, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Lower middle income recorded 86.6% for immunization, hib3 in 2024. That is the highest value across all 35 years on record.
The figure is up 1.3% on the previous year and up 66.0% over ten years.
Over the whole period, immunization, hib3 in Lower middle income peaked at 86.6% in 2024 and was at its lowest, 0.0%, in 1990.
Lower middle income ranks 15th of 43 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in Lower middle income, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.0% | — |
| 1998 | 0.0% | — |
| 1999 | 0.2% | — |
| 2000 | 0.9% | +353.8% |
| 2001 | 1.3% | +37.0% |
| 2002 | 4.2% | +231.6% |
| 2003 | 4.4% | +3.8% |
| 2004 | 5.1% | +17.3% |
| 2005 | 5.9% | +14.5% |
| 2006 | 6.3% | +8.1% |
| 2007 | 8.5% | +33.3% |
| 2008 | 9.6% | +13.4% |
| 2009 | 27.9% | +190.6% |
| 2010 | 29.1% | +4.4% |
| 2011 | 31.0% | +6.5% |
| 2012 | 33.2% | +7.0% |
| 2013 | 45.1% | +36.0% |
| 2014 | 52.1% | +15.6% |
| 2015 | 63.1% | +21.1% |
| 2016 | 79.4% | +25.8% |
| 2017 | 82.8% | +4.2% |
| 2018 | 84.6% | +2.2% |
| 2019 | 85.9% | +1.6% |
| 2020 | 81.8% | -4.8% |
| 2021 | 81.3% | -0.5% |
| 2022 | 85.1% | +4.6% |
| 2023 | 85.5% | +0.5% |
| 2024 | 86.6% | +1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.2% | 10 |
| 2000s | 7.4% | 0.9% | 27.9% | 10 |
| 2010s | 58.6% | 29.1% | 85.9% | 10 |
| 2020s | 84.0% | 81.3% | 86.6% | 5 |
More health data for Lower middle income
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.33 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.0359 units per person (2025)
- Population ages 40-44, female, annual growth rate 2.83 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 2.59 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0321 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, per capita 0.0347 units per person (2025)
- Population ages 40-44, female, per capita 0.031 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Lower middle income?
- Immunization, hib3 in Lower middle income was 86.6% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Lower middle income?
- The highest recorded value was 86.6% in 2024.
- What is the lowest immunization, hib3 recorded in Lower middle income?
- The lowest recorded value was 0.0% in 1990.
- How does Lower middle income rank for immunization, hib3?
- Lower middle income ranks 15th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Lower middle income?
- Over the last ten years it is up 66.0%. The long-run trend across the full record is volatile.
- Where does this Lower middle income data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.